NEW YORK, NY ACCESSWIRE / November 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Northwest Biotherapeutics Inc (NASDAQ: NWBO),Elite Pharmaceuticals Inc (OTC: ELTP), Barrett Business Services Inc (NASDAQ: BBSI) and Ekso Bionics Holdings Inc (OTC: EKSO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
NWBO Research Package: http://www.traders-choice.com/pdf?s=NWBO
ELTP Research Package: http://www.traders-choice.com/pdf?s=ELTP
BBSI Research Package: http://www.traders-choice.com/pdf?s=BBSI
EKSO Research Package: http://www.traders-choice.com/pdf?s=EKSO
============
Highlights from today's reports include:
On Friday, November 13, 2015, Nasdaq Composite ended at 4,927.88, down 1.54%, Dow Jones Industrial Average declined 1.16% to finish the day at 17,245.24, and S&P 500 closed at 2,023.04, down 1.12%.
- Northwest Biotherapeutics Inc's stock edged higher by 0.44% to close Friday's session at USD 4.54 with a total market capitalization of USD 419.31 million. The company's shares oscillated between USD 4.38 and USD 4.75. The stock recorded a trading volume of 0.36 million shares, which was below its 50-day daily average volume of 0.52 million shares and below its 52-week average volume of 0.58 million shares. Over the last three days, Northwest Biotherapeutics Inc's shares have declined by 9.20% and in the past one week it has moved down 13.85%. The company has an Enterprise Value of USD 436.69 million with an Enterprise Value to Revenue (TTM) ratio of 249.82. The company has price to sales (TTM) ratio of 238.82 and a Relative Strength Index (RSI) of 26.16.
- The stock of Elite Pharmaceuticals Inc lost 4.55% to close Friday's session at USD 0.30 with a total market capitalization of USD 202.69 million. The shares of the company moved in the range of USD 0.29 and USD 0.31. A trading volume of 2.99 million shares was recorded, which was greater than its 150-day daily average volume of 1.26 million shares and above its 52-week average volume of 1.40 million shares. The stock has a Relative Strength Index (RSI) of 53.17. In the last one month, Elite Pharmaceuticals Inc's shares have gained 34.55%. Additionally, over the last six months, the stock has advanced 34.55%. The company has returned 37.67% in the last three months, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 7.47, higher than its historical PE ratio of 6.42. The stock is trading above its 50-day and 200-day moving averages of USD 0.27 and USD 0.23, respectively.
- The stock of Barrett Business Services Inc gained 1.81% to close Friday's session at USD 39.36. The shares of the company moved in the range of USD 37.71 and USD 39.79. A trading volume of 0.15 million shares was recorded, which was greater than its 150-day daily average volume of 0.14 million shares. Over the last five days, Barrett Business Services Inc's shares have declined by 24.41%. However, over the last three months, the stock has advanced 4.57% and in the past six months, the shares have registered a profit of 3.44%. Barrett Business Services Inc has a current dividend yield of 2.24%. Further, the company is trading at a price to earnings (TTM) ratio of 13.48 and at a price to book (MRQ) ratio of 5.49. Further, the stock is trading at a price to cash flow (TTM) ratio of 15.43 and price to sales (TTM) ratio of 0.38.
- Ekso Bionics Holdings Inc's stock added 5.93% to close Friday's session at USD 1.25. The company's shares oscillated between USD 1.17 and USD 1.25. The stock recorded a trading volume of 0.29 million shares, which was below its 50-day daily average volume of 0.32 million shares and below its 52-week average volume of 0.58 million shares. The company has a market capitalization of USD 127.99 million and an Enterprise Value USD 116.83 million with an EV / Revenue (TTM) ratio of 14.25. Additionally, the company is trading at a price to sales (TTM) ratio of 14.74 and price to book (MRQ) ratio of 13.11. Further, the company is trading at a price to earnings ratio of 2.67. Over the last five days, Ekso Bionics Holdings Inc's shares have advanced 8.70%. In addition, over the last three months, the stock has gained 19.05%. The company has returned 10.62% in the past one month, on a compounded total return basis.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice